 DORADO, PUERTO RICO ACCESSWIRE September 14, 2021 Pharma-Bio Serv, Inc. Pharma-Bio Serv or the Company OTCQB:PBSV, a regulatory, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced revenues for the three and nine months ended July 31, 2021 were approximately 4,988,000 and 14,518,000, respectively, a decrease of approximately 1,290,000 and 2,021,000, respectively, when compared to the same periods last year. Net income for the three and nine months ended July 31, 2021 was approximately 2,275,000 and 2,783,000, an increase of approximately 1,583,000 and 876,000 when compared to the same periods last year, respectively. 